Cutting-Edge Research Results Showcase AI-Powered Drug Discovery VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) — Rakovina...
Vous n'êtes pas connecté
AI-powered screening reveals promising RIPK3 inhibitors for glaucoma therapy.
Cutting-Edge Research Results Showcase AI-Powered Drug Discovery VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) — Rakovina...
Cutting-Edge Research Results Showcase AI-Powered Drug Discovery VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) — Rakovina...
Tom Fulmer Presenting at the 2025 NDASA Annual Conference National Drug Screening earns BBB Accreditation NDASA Recognizes NDS With C/TPA...
Tom Fulmer Presenting at the 2025 NDASA Annual Conference National Drug Screening earns BBB Accreditation NDASA Recognizes NDS With C/TPA...
The Internet has always been a space for free expression, collaboration, and the open exchange of ideas. However, with persistent advances in...
Preferental founder and CEO Ross Fitzcharles explains the platform's AI-powered tenant screening features.